- Home
- IRWD vs NIE Comparison
IRWD vs NIE Comparison
Compare IRWD & NIE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IRWD
- NIE
- Stock Information
- Founded
- IRWD 1998
- NIE 2007
- Country
- IRWD United States
- NIE United States
- Employees
- IRWD N/A
- NIE N/A
- Industry
- IRWD Biotechnology: Pharmaceutical Preparations
- NIE Investment Managers
- Sector
- IRWD Health Care
- NIE Finance
- Exchange
- IRWD Nasdaq
- NIE Nasdaq
- Market Cap
- IRWD 734.5M
- NIE 655.0M
- IPO Year
- IRWD 2010
- NIE N/A
- Fundamental
- Price
- IRWD $3.66
- NIE $24.78
- Analyst Decision
- IRWD Buy
- NIE
- Analyst Count
- IRWD 4
- NIE 0
- Target Price
- IRWD $12.00
- NIE N/A
- AVG Volume (30 Days)
- IRWD 2.4M
- NIE 70.5K
- Earning Date
- IRWD 02-13-2025
- NIE 01-01-0001
- Dividend Yield
- IRWD N/A
- NIE 9.04%
- EPS Growth
- IRWD N/A
- NIE N/A
- EPS
- IRWD N/A
- NIE N/A
- Revenue
- IRWD $378,418,000.00
- NIE N/A
- Revenue This Year
- IRWD N/A
- NIE N/A
- Revenue Next Year
- IRWD N/A
- NIE N/A
- P/E Ratio
- IRWD N/A
- NIE N/A
- Revenue Growth
- IRWD N/A
- NIE N/A
- 52 Week Low
- IRWD $3.06
- NIE $18.61
- 52 Week High
- IRWD $15.70
- NIE $22.47
- Technical
- Relative Strength Index (RSI)
- IRWD 40.23
- NIE 58.28
- Support Level
- IRWD $3.56
- NIE $23.41
- Resistance Level
- IRWD $3.88
- NIE $24.50
- Average True Range (ATR)
- IRWD 0.31
- NIE 0.53
- MACD
- IRWD -0.10
- NIE 0.05
- Stochastic Oscillator
- IRWD 10.40
- NIE 83.54
About IRWD Ironwood Pharmaceuticals Inc.
Ironwood Pharmaceuticals Inc is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities.
About NIE Virtus Equity & Convertible Income Fund of Beneficial Interest
Virtus AllianzGI Equity & Convertible Income Fund is a diversified, closed-end management investment company. Its investment objective is to seek total return comprised of capital appreciation, current income, and gains. The fund pursues its objective by investing in a diversified portfolio of equity securities and income-producing convertible securities. Its portfolio of investments comprises different sector investments such as aerospace and defense, banks, IT services, software, and others.